Drug application
CORTISPORIN (HYDROCORTISONE ACETATE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE)
Drugs@FDA NDA 050218 · MONARCH PHARMS
Key facts
| Drug name | CORTISPORIN |
|---|---|
| Active ingredients | HYDROCORTISONE ACETATE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE |
| Application type | NDA |
| Application number | 050218 |
| Company | MONARCH PHARMS |
| Dosage forms | CREAM, TOPICAL |
| Strength | 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission status date | Apr 16, 1963 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: